Anti-angiogenesis Therapy
Anti-angiogenesis therapy is one of the newest treatments in the fight against cancer. It works by blocking angiogenesis, the formation of new blood vessels, which tumors need to grow. By cutting off this vital blood supply, the therapy starves the tumor, making it harder for cancer cells to proliferate.
How Anti-Angiogenesis Therapy Targets Tumor Growth
Angiogenesis plays a crucial role in the growth and spread of solid tumors, including those in the breast, lungs, and kidneys. Anti-angiogenesis therapy targets this process by inhibiting vascular endothelial growth factor (VEGF), which is essential for new blood vessel formation. This therapy is often used in combination with other treatments, like chemotherapy, to enhance the overall treatment effectiveness.
The Role of Anti-Angiogenesis Therapy we’ll explore how anti-angiogenesis therapy works, its key benefits, and why it is an integral part of cancer treatment today. We’ll also explain how OncoLife incorporates this therapy into its comprehensive cancer care plans.
How Anti-Angiogenesis Therapy Works
Angiogenesis plays a critical role in the growth and spread of solid tumors, including those in the breast, lungs, and kidneys. Anti-angiogenesis therapy targets this process by inhibiting vascular endothelial growth factor (VEGF), essential for blood vessel formation. Anti-angiogenic agents, such as angiogenesis inhibitors, block these signals to cut off the tumor’s blood supply, slowing its growth.
These therapies are often combined with chemotherapy to improve overall treatment effectiveness. Approved by the Food and Drug Administration (FDA), anti-angiogenic drugs are used to treat cancers like colorectal, lung, and kidney cancer. As research advances, new anti-angiogenic agents and combinations are being developed to offer more personalized and effective treatment options.
The Role of VEGF in Tumor Growth
VEGF is a key factor that tumors produce to stimulate the growth of new blood vessels. These new vessels help tumors grow larger and facilitate the spread of cancer cells to other parts of the body. By targeting VEGF and its receptors, anti-angiogenesis therapy effectively cuts off the tumor’s blood supply, which slows its growth and reduces the potential for metastasis.
Blocking Signaling Pathways to Stop Blood Vessel Formation
Tumors use signaling pathways to send messages that start new blood vessel growth. Anti-angiogenesis therapy blocks these pathways. One way to block these signals is by using monoclonal antibodies, which are special lab-made proteins. They attach to VEGF or its receptors and stop the messages from reaching their targets. When the messages stop, the tumor cannot build the blood supply it needs. This slows down its growth and makes it harder for cancer to spread.
Why Choose OncoLife for Anti-Angiogenesis Therapy
OncoLife is committed to providing the latest and most effective anti-angiogenesis therapies for cancer patients. Tumor cells often rely on the formation of new blood vessels through angiogenesis to supply nutrients and oxygen.
By targeting this process, anti-angiogenic therapy disrupts the tumor’s ability to grow and spread. This treatment also affects the extracellular matrix, which supports tumor structure and function. At OncoLife, we offer cutting-edge anti-angiogenic therapies to target these critical pathways, improving patient outcomes and slowing tumor progression. Here’s why you should choose OncoLife:
Specialized Expertise
Our Oncologists is skilled in delivering advanced anti-angiogenesis therapy. We tailor each treatment plan to meet the specific needs of our patients, ensuring the best possible outcomes.
Personalized Treatment Plans
At OncoLife, we understand that every cancer case is unique. Our specialists design personalized anti-angiogenesis therapy plans based on each patient’s diagnosis, medical history, and treatment goals for the most effective results.
Ongoing Monitoring and Support
We believe continuous care is key to success. Our team provides regular monitoring and follow-ups throughout your treatment journey, ensuring timely adjustments and offering full support every step of the way.
Key Benefits of Anti-Angiogenesis Therapy
Anti-angiogenesis therapy blocks the blood supply to tumors, preventing them from growing or spreading. It has fewer side effects than chemotherapy, improving patients’ quality of life. This therapy can also be used with other treatments, making them more effective.
It helps stop cancer from spreading, improves survival rates, and can prevent recurrence by stopping new blood vessels from forming. Non-invasive and easier to tolerate, it also supports wound healing. FDA-approved and safe, it enhances treatment outcomes and boosts the chances of long-term remission.
Targeting Tumor Blood Supply
Tumors cannot grow without blood. Anti-angiogenesis therapy works by stopping the tumor from getting the blood it needs. Without a blood supply, the tumor cannot grow or spread. This therapy blocks the signals that help the tumor create new blood vessels, making it harder for the tumor to survive.
Blocking Blood Vessel Formation
This therapy works well for many types of solid tumors, like breast cancer, lung cancer, and kidney cancer. By cutting off the tumor’s blood supply, the tumor can’t grow as fast. As a result, the tumor shrinks or slows its growth significantly.
Minimizing Side Effects
Traditional cancer treatments, such as chemotherapy, harm both cancerous and healthy cells. This often causes side effects like hair loss, nausea, and extreme tiredness. However, anti-angiogenesis therapy targets only the tumor’s blood vessels. This focused action results in fewer side effects, making the treatment easier for patients to handle.
Focused Targeting
Since anti-angiogenesis therapy only affects the tumor’s blood supply, it doesn’t damage healthy tissues as much. This means patients often experience fewer side effects compared to chemotherapy or radiation treatments. It makes the treatment more manageable and improves the overall quality of life during therapy.
Complementary Treatment with Other Therapies
Anti-angiogenesis therapy works well with other cancer treatments, like chemotherapy, radiation, or surgery. When this therapy blocks the blood supply to the tumor, it makes other treatments more effective. With fewer blood vessels feeding the tumor, chemotherapy and radiation can reach the tumor more easily.
Synergistic Effect with Chemotherapy
Using anti-angiogenesis therapy alongside chemotherapy or radiation increases the chances of a successful treatment. This combination can make chemotherapy more effective by allowing it to target the tumor more directly. It also helps reduce the likelihood of cancer returning.
Slowing Down Cancer Metastasis
Metastasis happens when cancer spreads to other parts of the body. Anti-angiogenesis therapy helps stop this by blocking the blood vessels that carry cancer cells to distant organs. This is especially helpful for cancers that tend to spread quickly, such as breast cancer and small cell lung cancer.
Preventing the Spread of Cancer
By blocking the blood supply to the tumor, this therapy makes it harder for cancer to spread. This reduces the risk of the cancer reaching other areas of the body and increases the patient’s chances of recovery.
Improving Survival Rates
Research shows that anti-angiogenesis therapy can help people live longer. By cutting off the tumor’s blood supply, it slows down the tumor’s growth and reduces complications. This means patients often survive longer and have a better chance of going into remission. This therapy has proven successful in treating various cancers, such as breast cancer, lung cancer, and kidney cancer.
Impact on Long-Term Survival
With less tumor growth and fewer complications, patients who use anti-angiogenesis therapy tend to live longer. They can also maintain a better quality of life during their treatment, which improves their overall well-being.
Reducing the Risk of Cancer Recurrence
Even after successful treatment, cancer can come back. Anti-angiogenesis therapy helps prevent this by stopping the tumor from regrowing. This therapy blocks the creation of new blood vessels that would allow the tumor to grow again. By preventing blood flow to the tumor, it’s much harder for the cancer to return.
Preventing Tumor Regrowth
In some cases, this therapy is used after initial cancer treatments to keep the tumor from returning. This helps lower the risk of recurrence and improves long-term outcomes.
Applications in Cancer Treatment
Anti-angiogenesis therapy is effective for treating various types of cancer, including:
Breast Cancer
In breast cancer, tumors need a constant blood supply to grow. Anti-angiogenesis therapy blocks blood vessels around the tumor, preventing its growth. This therapy is often combined with chemotherapy for more effective treatment.
Small Cell Lung Cancer
Small cell lung cancer is aggressive and spreads rapidly. Anti-angiogenesis therapy helps slow its growth by blocking new blood vessel formation. This treatment is often combined with chemotherapy, increasing survival rates and treatment success.
Solid Tumors
anti angiogenic drugsAnti-angiogenesis therapy is effective against solid tumors in organs such as the liver, kidneys, and pancreas. These tumors rely on angiogenesis for growth, so stopping this process can significantly slow down tumor development.
Conclusion: The Future of Anti-Angiogenesis Therapy
Anti-angiogenesis therapy is becoming a crucial part of cancer treatment, offering patients a powerful option to combat tumors by targeting their blood supply. This therapy prevents tumors from growing and spreading by blocking the formation of new blood vessels. As research continues to advance, new drugs and innovative methods are making anti-angiogenesis therapy more effective and accessible.
Innovative Treatment at OncoLife
At OncoLife, we integrate this cutting-edge treatment into our comprehensive cancer care plans. Our expert team works closely with you to develop a personalized treatment strategy tailored to your specific needs. With ongoing support and guidance, we are committed to helping you achieve the best possible outcome throughout your cancer journey.
OncoLife’s Commitment to Advanced Cancer Care
Anti-angiogenesis therapy is transforming cancer treatment by targeting tumors’ blood supply to prevent their growth and spread. At OncoLife, we bring the latest advancements in anti-angiogenesis therapy to our patients, offering personalized care and treatment plans that address each individual’s needs.
Our expert team at this state-of-the-art facility is dedicated to providing the most effective treatments, including anti-angiogenesis therapy, to support your journey toward recovery. With cutting-edge technology and a compassionate approach, we aim to offer the highest level of care to ensure the best possible outcomes for our patients.
Opening Hours:
Monday to Friday: 7.30am – 5.00pm
Saturday: 7.30am to 1.00pm
Sunday: Closed
For inquiries, please contact us at:
Phone: +60 12-399 3260 / +60 3 2242 3260
Email: info@oncolifecentre.com
Your Journey
Start Your Recovery
Our dedicated Patient Navigator will assist you with appointment scheduling. Contact us at +6012-3993260 (Call or Whatsapp ).
First Consultation
On appointment day, bring along all the medical reports and your identity documents, ie. identity card or passport. Our team will help you organize the medical reports for our oncologist to review. Our oncologist will discuss the treatment plan with you. Tele-consult is available for overseas patients.
Treatment Day
Come to our center on an agreed date and time for the treatment. Our team will take good care of you. You will be discharged on the same day. Yes, you will get to go home after every treatment visit as no overnight admission is required.
Stay on Track
Our dedicated patient navigator will be following up with you post treatment to check on your condition, to ensure that you are doing well. You will receive a reminder message on your phone for the next appointment date.
Onco Life Centre Wins 2025 Best Oncology Clinic in Malaysia
We are proud to share that Onco Life Centre has been named the Oncology Clinic and Treatment Centre of the Year in Malaysia at the GlobalHealth Asia-Pacific Awards 2025, held in Bangkok.
This prestigious recognition is a testament to our unwavering commitment to delivering personalized, compassionate, and cutting-edge cancer care to our patients. The award reflects not just our clinical excellence, but our dedication to safety, community outreach, and innovation in oncology services.
The GlobalHealth Asia-Pacific Awards celebrate leading healthcare institutions across the region. Winners are chosen based on a comprehensive evaluation of criteria such as:
Excellence and Innovation: Transforming healthcare delivery and patient outcomes through progressive medical practices.
Patient Safety: Upholding the highest standards to ensure safe, comfortable, and effective treatment environments.
Community Involvement: Actively engaging in public awareness, screening programs, and care for underprivileged communities.
Technology Adoption: Integrating advanced diagnostics, therapies, and digital tools to enhance every aspect of care.
Impact and Measurable Results: Demonstrating tangible improvements in cancer detection, treatment success, and patient well-being.
Adaptability and Preparedness: Being resilient and forward-thinking in the face of global health challenges.
Leadership and Vision: Cultivating a culture that prioritizes empathy, innovation, and ongoing education.
This award inspires us to continue raising the bar in oncology care—not only through medical advancements but by remaining deeply rooted in our advocacy mission: to serve, educate, and empower every cancer patient, especially those most in need.
We dedicate this achievement to our patients, survivors, caregivers, and the entire Onco Life Centre community. Your courage fuels our purpose. Together, we will continue the fight—because every life matters.
NSCLC (Non-small cell lung cancer)
2010 Breast and Lung Cancer Awareness Campaign (LEMBAH PANTAI)
2011 Colorectal Cancer Screening and Treatment Community Project (GOMBAK AND SELAYANG)
2011 & 2012 Colorectal Cancer Awareness, Screening and Treatment Community Project (SETAPAK)
2012 Colorectal Cancer Screening and Treatment Community Project (LEMBAH SUBANG)
2014 Colorectal Cancer Awareness, Screening and Treatment Community Project (CHERAS)
2015 Colorectal Cancer Awareness, Screening and Treatment Project (HILIRAN AMPANG)
2016 Colorectal Cancer Awareness, Screening and Treatment Project (DESA TUN RAZAK)
Credentials You Can Trust
Ministry of Health Malaysia
Onco Life Centre is fully licensed as an Oncology Consultation and Treatment Centre (License No: 931401-00214-03/2024)
DR. CHRISTINA NG VAN TZE
CONSULTANT MEDICAL ONCOLOGIST (NSR: 131550)
MBBS (MELB), FELLOW RACP (AUS)
DR. JOSEPH KANIANTHRA JOSEPH
CONSULTANT MEDICAL ONCOLOGIST (NSR: 124660)
MBBCH, BAO (IRE), MRCP (UK)
Service Area
Onco Life Centre location
Download our booklet
about Colorectal cancer for FREE
